In this week’s Solidarity Fridays episode, inspired by their conversation with James Fadiman from a few weeks ago, Joe Moore and Kyle Buller dive into all things microdosing: Why people are doing it, what they’re using, possible negative effects, how it could work with pain (pain management and/or neurogenesis), what other indications it could help, what other life variables are at play when microdosing, and how the classic self-blinding study that many deemed the death knell for microdosing should actually be seen as the beginning of a long road of research. Joe then shares an Instagram post from author Kelly Starrett that sarcastically showcases the problems with physical therapy in a careless healthcare system, which leads to a conversation about how one decides what a good outcome is in mental health therapy.

The post PTSF89 – A Macro Dive Into Microdosing appeared first on Psychedelics Today.

Previous articleMYND Life Sciences Provides Update on Depression Gene Modulation Pathway Patent Application
Next articleMYND Life Sciences Acquires Rights for the Use of Psychedelics to Treat Alzheimer’s Disease and other Dementias